.tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] > .tb-grid-column:nth-of-type(3n + 1) { grid-column: 1 } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] > .tb-grid-column:nth-of-type(3n + 2) { grid-column: 2 } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] > .tb-grid-column:nth-of-type(3n + 3) { grid-column: 3 } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .js-wpv-loop-wrapper > .tb-grid { grid-template-columns: minmax(0, 0.3333fr) minmax(0, 0.3333fr) minmax(0, 0.3333fr);grid-auto-flow: row } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .tb-masonry { grid-template-columns: minmax(0, 1fr) minmax(0, 1fr);grid-column-gap: 10px; } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .tb-masonry .tb-brick__content { padding: 0 0 10px 0; } .wpv-pagination-nav-links[data-toolset-views-view-pagination-block="95f5751cc2f80f4b7d21b100ff8b624f"] { text-align: left;justify-content: flex-start; } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="40b05292f70a70284b1c1668151484af"] { background: rgba( 250, 246, 246, 1 );padding: 0px;border: 1px solid rgba( 218, 218, 218, 1 ); } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="15799f218876513e85a62246af23d50a"] { padding: 15px 20px 10px 20px;margin-top: 0px;border: 0px solid rgba( 0, 0, 0, 1 ); } .tb-fields-and-text[data-toolset-blocks-fields-and-text="8d670a655444748b596f1fb0c7115269"] { color: rgba( 0, 0, 0, 1 );margin-bottom: 10px; } .tb-fields-and-text[data-toolset-blocks-fields-and-text="8d670a655444748b596f1fb0c7115269"] p { color: rgba( 0, 0, 0, 1 ); }  .tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} .tb-button[data-toolset-blocks-button="d38c7b1e6196431e002ed2a380201dca"] .tb-button__link { background-color: rgba( 207, 46, 46, 1 );font-size: 12px;text-transform: capitalize; } .tb-button[data-toolset-blocks-button="d38c7b1e6196431e002ed2a380201dca"] .tb-button__icon { font-family: dashicons; } .tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} .tb-button[data-toolset-blocks-button="20359d45c52c74fddb37f562d17a0d03"] .tb-button__link { background-color: rgba( 6, 147, 227, 1 );font-size: 12px;text-transform: capitalize; } .tb-button[data-toolset-blocks-button="20359d45c52c74fddb37f562d17a0d03"] .tb-button__icon { font-family: dashicons; } @media only screen and (max-width: 781px) { .tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] > .tb-grid-column:nth-of-type(3n + 1) { grid-column: 1 } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] > .tb-grid-column:nth-of-type(3n + 2) { grid-column: 2 } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] > .tb-grid-column:nth-of-type(3n + 3) { grid-column: 3 } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .js-wpv-loop-wrapper > .tb-grid { grid-template-columns: minmax(0, 0.3333fr) minmax(0, 0.3333fr) minmax(0, 0.3333fr);grid-auto-flow: row } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .tb-masonry { grid-template-columns: minmax(0, 1fr) minmax(0, 1fr);grid-column-gap: 10px; } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .tb-masonry .tb-brick__content { padding: 0 0 10px 0; } .tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto} .tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em}.tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} } @media only screen and (max-width: 599px) { .tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"]  > .tb-grid-column:nth-of-type(1n+1) { grid-column: 1 } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .js-wpv-loop-wrapper > .tb-grid { grid-template-columns: minmax(0, 1fr);grid-auto-flow: row } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .tb-masonry { grid-template-columns: minmax(0, 1fr);grid-column-gap: 10px; } .wpv-view-output[data-toolset-views-view-editor="398b1c497a9ce286fa1c53fda77b18cb"] .tb-masonry .tb-brick__content { padding: 0 0 10px 0; } .tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto} .tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em}.tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} } 

Roche raise sales expectations

May 12, 2005
Sales and Marketing

Roche has raised its full-year sales forecast after strong first quarter results saw the Swiss company outperform a number of …

News

Monoclonal antibody sales set to rocket

May 12, 2005
Sales and Marketing

The monoclonal antibody market will treble in size to $30 billion by 2010, according to a report by analysts Datamonitor.Datamonitor …

News

Novartis files novel iron overload treatment

May 12, 2005
Sales and Marketing

A new treatment for the rare and difficult to treat condition of chronic iron overload has been filed by Novartis …

News

FDA approves Requip for restless legs syndrome

May 12, 2005
Sales and Marketing

GlaxoSmithKline's Requip has become the first medicine to receive US approval for the treatment of restless legs syndrome (RLS), after …

News

Increasing salesforce effectiveness

May 11, 2005
Sales and Marketing

Pfizer will cut costs worth $4 billion over the next three years in an attempt to return to double-digit earnings …

Feature

10 Brand Blunders…And How to Avoid Them

May 10, 2005
Sales and Marketing

1) Stay loyal to the core brand message and never undermine itIt may have seemed a good idea at the …

Feature

Stepping out: the contract salesforce

May 10, 2005
Sales and Marketing

Sales forces in the pharmaceutical industry account for around 75% of marketing budgets, and are coming under increasing pressure to …

Feature

Gilmartin to leave troubled Merck

May 6, 2005
Sales and Marketing

Raymond Gilmartin has stood down as chief executive and chairman of Merck, drawing a line under long-running uncertainty regarding the …

News

Charity aiming to ‘hit diabetes for six’

May 6, 2005

News

Health helps Labour win third term

May 6, 2005

News

GSK makes strategic biotech acquisition

May 6, 2005
Research and Development, Sales and Marketing GSK, biotech

GlaxoSmithKline will acquire a Seattle-based biotech that manufactures a key component in many of the candidates in its vaccine pipeline, …

News

Crestor sales top $1 billion for AstraZeneca

May 6, 2005
Sales and Marketing

AstraZeneca's Crestor has achieved blockbuster status, despite continuing concerns over its safety, registering sales of over $1 billion for the …

News

Lilly’s first-in-class diabetes drug approved in US

May 5, 2005
Sales and Marketing

Lilly has gained US marketing approval for Byetta, the first in a new class of type II diabetes treatments derived …

News

Mixed news for AstraZeneca’s stroke drug Cerovive

May 4, 2005
Research and Development, Sales and Marketing

AstraZeneca has received a boost from its phase III drug Cerovive, with clinical trial data showing the treatment can reduce …

News

Does your brand need a check-up?

May 4, 2005
Sales and Marketing

Brands are all about 'adding value'. To provide this value to our target customers we need to ensure we have …

Feature

Filling in the gaps in your team

May 4, 2005
Business Services

Outsourcing as an integral element of a business strategy has waxed and waned in popularity and acceptability over the last …

Feature

Taking on the market leader

May 4, 2005
Sales and Marketing

Launching a new product into a therapeutic area dominated by a 'gold standard' doctors' favourite is a tough task but …

Feature

Velcade moves up to second line treatment

April 28, 2005
Sales and Marketing

Ortho Biotech's Velcade has received approval as a second-line treatment for patients with multiple myeloma in Europe, advancing it from …

News

EMEA advises against prescribing of antidepressants in children

April 28, 2005
Sales and Marketing

Doctors across Europe will be discouraged from prescribing most modern antidepressants for children and adolescents following new EMEA advice.Investigations into …

News